HealthEquity, Inc. (HQY) Q3 2026 Earnings Call Transcript

1 min read
1 views

HealthEquity, Inc. (HQY) Q3 2026 Earnings Call December 3, 2025 4:30 PM EST

Company Participants

Richard Putnam – Vice President of Investor Relations
Scott Cutler – CEO, President & Director
Stephen D. Neeleman – Founder & Vice Chairman
James Lucania – CFO & Executive VP

Conference Call Participants

Stanislav Berenshteyn – Wells Fargo Securities, LLC, Research Division
Allen Lutz – BofA Securities, Research Division
George Hill – Deutsche Bank AG, Research Division
Mark Marcon – Robert W. Baird & Co. Incorporated, Research Division
Brian Tanquilut – Jefferies LLC, Research Division
Sean Dodge – BMO Capital Markets Equity Research
Scott Schoenhaus – KeyBanc Capital Markets Inc., Research Division
Steven Valiquette – Mizuho Securities USA LLC, Research Division
Charles Peters – Raymond James & Associates, Inc., Research Division
David Roman – Goldman Sachs Group, Inc., Research Division
David Larsen – BTIG, LLC, Research Division

Presentation

Operator

Good day, and welcome to the HealthEquity Third Quarter 2026 Earnings Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Richard Putnam. Please go ahead.

Richard Putnam
Vice President of Investor Relations

Thank you, Dave. Hello, everyone. Thank you for joining us this afternoon. This is HealthEquity’s Third Quarter Fiscal Year 2026 Earnings Conference Call. My name is Richard Putnam. I do Investor Relations for HealthEquity. Joining me today are Scott Cutler, President and CEO; Dr. Steve Neeleman, Vice Chair and Founder of the company; and James Lucania, Executive Vice President and CFO. Before I turn the call over to Scott for prepared remarks, we note that a press release announcing our third quarter financial results was issued after the market closed this afternoon and that it included certain non-GAAP financial measures that we will reference here today.

You can find a copy of today’s press release, including reconciliation of these non-GAAP measures with comparable GAAP measures

Read the full article here

Leave a Reply

Your email address will not be published.

Previous Story

MSCI Inc. (MSCI) Presents at UBS Global Technology and AI Conference 2025 Transcript

Latest from News